The Live Zoster Vaccine is an active attenuated vaccine used to prevent shingles. Its main component is a weakened live strain of the varicella-zoster virus (VZV), which stimulates the immune system to produce specific immune responses, thereby providing protection against shingles.
Shingles is a disease caused by the varicella-zoster virus (VZV), typically manifesting as painful skin blisters localized to specific areas, often accompanied by neuralgia. The disease is more common in individuals with weakened immune systems or older adults.
The Live Zoster Vaccine is classified as a live attenuated vaccine, which triggers an immune response through weakened viral strains. The virus strains in the vaccine are attenuated and generally do not cause clinical symptoms but are sufficient to stimulate the immune system to produce antibodies and memory lymphocytes against VZV.
After vaccination, the immune system recognizes and destroys the vaccine virus and remembers its antigenic properties, enabling a quick and effective response upon future encounters with wild-type virus, thus reducing the risk of disease.
The Live Zoster Vaccine is primarily used to prevent shingles, especially in individuals aged 50 and above. The incidence of shingles increases with age, so the vaccine is recommended as a routine immunization for adults.
Additionally, the vaccine can be used for high-risk groups such as immunocompromised individuals, diabetics, and those on long-term corticosteroid therapy, who are at higher risk of developing shingles and its severe complications.
The vaccine is usually administered via subcutaneous injection, with a single dose of 0.5 mL. It is recommended that adults receive one dose to provide long-term immunity.
According to vaccination guidelines, it is advised for individuals aged 50 and above to receive the vaccine, even if they have previously had shingles, to reduce the risk of recurrence.
The main advantages of the Live Zoster Vaccine include its high efficacy in prevention. Studies show that vaccination reduces the incidence of shingles by about 50% and significantly decreases the occurrence of postherpetic neuralgia (PHN).
The Live Zoster Vaccine is generally safe, but like all medications, it may cause side effects. Common side effects include redness, swelling, pain at the injection site, or fever, which are usually mild and resolve within a few days.
In rare cases, allergic reactions such as rash, difficulty breathing, or facial swelling may occur, requiring immediate medical attention.
The Live Zoster Vaccine has the following precautions and contraindications:
The Live Zoster Vaccine may interact with other medications or treatments. Patients should inform their healthcare provider of all medications they are taking, especially immunosuppressants and corticosteroids, before vaccination.
Furthermore, it is recommended to wait at least one month after vaccination before receiving other live vaccines to prevent interference with immune responses.
Multiple clinical trials have confirmed the significant efficacy of the Live Zoster Vaccine in preventing shingles. For example, clinical trials of the SHINGRIX vaccine show about 90% effectiveness in preventing shingles and a similarly high efficacy in preventing postherpetic neuralgia.
Additionally, the protective effect of the vaccine can last for many years, providing long-term immunity for high-risk populations.
Currently, the Live Zoster Vaccine is the primary method for preventing shingles. However, for individuals who cannot receive live vaccines, other preventive measures such as antiviral medications may be considered.
For those already affected by shingles, doctors may prescribe antiviral drugs (e.g., acyclovir) to alleviate symptoms and prevent complications.
Before receiving the live shingles vaccine, it is recommended to avoid immunosuppressive medications and ensure your health is stable. If you have a history of severe allergies or are undergoing chemotherapy, consult your doctor beforehand. On the day of vaccination, wear loose clothing for easy access to the injection site and bring relevant medical records for assessment.
What are the possible side effects after receiving the live shingles vaccine?Most people may experience mild side effects such as redness, swelling, or pain at the injection site. Some may have mild fever or fatigue, which usually resolve within a few days. If severe allergic reactions such as difficulty breathing or facial swelling occur, seek medical attention immediately.
Why is it recommended for people aged 50 and above to receive the live shingles vaccine?As age increases, immune function gradually declines, increasing the risk of VZV infection and potentially leading to more severe complications. Vaccination can effectively stimulate the immune system to produce antibodies against the virus, reducing infection risk and severity of symptoms.
How should I handle side effects after receiving the live shingles vaccine?If mild side effects such as discomfort at the injection site occur, applying cold compresses can help. For fever, non-steroidal anti-inflammatory drugs like ibuprofen may be used to reduce temperature. Rest, maintain good personal hygiene, and avoid overexertion. If side effects persist or worsen, seek medical care promptly.
How effective is the live shingles vaccine?The effectiveness of the live shingles vaccine has been confirmed in clinical trials, with about 90% of vaccinated individuals significantly reducing their risk of VZV infection. It also decreases pain and complications caused by infection. The protective period is generally over five years, but immunity may decline over time, so periodic evaluation under medical guidance is recommended.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
